Presentation TCT 2017

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presenter: Angelo Biviano, MD

November 01, 2017

REGISTER for free or LOG IN to view this content

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presentation

TCT 2017

Aortic Valve

Up Next

Presentation TCT 2017

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Presenter: Nicolas M. Van Mieghem

November 01, 2017

More slides +

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

Concomitant Severe Tricuspid and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: Maurizio Taramasso

November 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.